Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Pharma & Healthcare
Published Date: 2025-03-19
Pages: 80 Pages
Report ld: 4683046
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2025-2031
11.8%
Market Size,2031
USD 4,251
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,177 million
Market Forecast in 2031(Value)
US$ 4,251 million
CAGR
11.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
The global Human Prothrombin Complex market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Prothrombin Complex market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 600 IU/Vial in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Vitamin K Deficiency in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 500 IU/Vial dominance in Europe vs. 600 IU/Vial demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Prothrombin Complex Product Scope
1.2 Human Prothrombin Complex by Type
1.2.1 Global Human Prothrombin Complex Sales by Type (2020 & 2024 & 2031)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex by Application
1.3.1 Global Human Prothrombin Complex Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Global Human Prothrombin Complex Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Prothrombin Complex Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Prothrombin Complex Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Prothrombin Complex Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Prothrombin Complex Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Prothrombin Complex Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Prothrombin Complex Sales Market Share by Region (2020-2025)
2.2.2 Global Human Prothrombin Complex Revenue Market Share by Region (2020-2025)
2.3 Global Human Prothrombin Complex Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Prothrombin Complex Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Prothrombin Complex Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Prothrombin Complex Market Size and Prospective (2020-2031)
2.4.2 Europe Human Prothrombin Complex Market Size and Prospective (2020-2031)
2.4.3 China Human Prothrombin Complex Market Size and Prospective (2020-2031)
2.4.4 Japan Human Prothrombin Complex Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Prothrombin Complex Historic Market Review by Type (2020-2025)
3.1.1 Global Human Prothrombin Complex Sales by Type (2020-2025)
3.1.2 Global Human Prothrombin Complex Revenue by Type (2020-2025)
3.1.3 Global Human Prothrombin Complex Price by Type (2020-2025)
3.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Prothrombin Complex Sales Forecast by Type (2026-2031)
3.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Prothrombin Complex Price Forecast by Type (2026-2031)
3.3 Different Types Human Prothrombin Complex Representative Players
4 Global Market Size by Application
4.1 Global Human Prothrombin Complex Historic Market Review by Application (2020-2025)
4.1.1 Global Human Prothrombin Complex Sales by Application (2020-2025)
4.1.2 Global Human Prothrombin Complex Revenue by Application (2020-2025)
4.1.3 Global Human Prothrombin Complex Price by Application (2020-2025)
4.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Prothrombin Complex Sales Forecast by Application (2026-2031)
4.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Prothrombin Complex Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Prothrombin Complex Application
5 Competition Landscape by Players
5.1 Global Human Prothrombin Complex Sales by Players (2020-2025)
5.2 Global Top Human Prothrombin Complex Players by Revenue (2020-2025)
5.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
5.4 Global Human Prothrombin Complex Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application
5.7 Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Prothrombin Complex Sales by Company
6.1.1.1 North America Human Prothrombin Complex Sales by Company (2020-2025)
6.1.1.2 North America Human Prothrombin Complex Revenue by Company (2020-2025)
6.1.2 North America Human Prothrombin Complex Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Prothrombin Complex Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Prothrombin Complex Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Prothrombin Complex Sales by Company
6.2.1.1 Europe Human Prothrombin Complex Sales by Company (2020-2025)
6.2.1.2 Europe Human Prothrombin Complex Revenue by Company (2020-2025)
6.2.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Prothrombin Complex Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Prothrombin Complex Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Prothrombin Complex Sales by Company
6.3.1.1 China Human Prothrombin Complex Sales by Company (2020-2025)
6.3.1.2 China Human Prothrombin Complex Revenue by Company (2020-2025)
6.3.2 China Human Prothrombin Complex Sales Breakdown by Type (2020-2025)
6.3.3 China Human Prothrombin Complex Sales Breakdown by Application (2020-2025)
6.3.4 China Human Prothrombin Complex Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Human Prothrombin Complex Sales by Company
6.4.1.1 Japan Human Prothrombin Complex Sales by Company (2020-2025)
6.4.1.2 Japan Human Prothrombin Complex Revenue by Company (2020-2025)
6.4.2 Japan Human Prothrombin Complex Sales Breakdown by Type (2020-2025)
6.4.3 Japan Human Prothrombin Complex Sales Breakdown by Application (2020-2025)
6.4.4 Japan Human Prothrombin Complex Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Takeda Human Prothrombin Complex Products Offered
7.1.5 Takeda Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.2.4 CSL Human Prothrombin Complex Products Offered
7.2.5 CSL Recent Development
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Grifols Human Prothrombin Complex Products Offered
7.3.5 Grifols Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Octapharma Human Prothrombin Complex Products Offered
7.4.5 Octapharma Recent Development
7.5 Hualan Biological
7.5.1 Hualan Biological Company Information
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Hualan Biological Human Prothrombin Complex Products Offered
7.5.5 Hualan Biological Recent Development
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Company Information
7.6.2 Meheco Xinxing Pharma Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
7.6.5 Meheco Xinxing Pharma Recent Development
8 Human Prothrombin Complex Manufacturing Cost Analysis
8.1 Human Prothrombin Complex Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Prothrombin Complex
8.4 Human Prothrombin Complex Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Prothrombin Complex Distributors List
9.3 Human Prothrombin Complex Customers
10 Human Prothrombin Complex Market Dynamics
10.1 Human Prothrombin Complex Industry Trends
10.2 Human Prothrombin Complex Market Drivers
10.3 Human Prothrombin Complex Market Challenges
10.4 Human Prothrombin Complex Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Human Prothrombin Complex Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Human Prothrombin Complex Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Human Prothrombin Complex Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Prothrombin Complex Sales (K Units) by Region (2020-2025)
Table 5. Global Human Prothrombin Complex Sales Market Share by Region (2020-2025)
Table 6. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Human Prothrombin Complex Revenue Share by Region (2020-2025)
Table 8. Global Human Prothrombin Complex Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Human Prothrombin Complex Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Human Prothrombin Complex Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Human Prothrombin Complex Revenue Share Forecast by Region (2026-2031)
Table 12. Global Human Prothrombin Complex Sales by Type (K Units) & (2020-2025)
Table 13. Global Human Prothrombin Complex Sales Share by Type (2020-2025)
Table 14. Global Human Prothrombin Complex Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Human Prothrombin Complex Price by Type (M USD/Unit) & (2020-2025)
Table 16. Global Human Prothrombin Complex Sales by Type (K Units) & (2026-2031)
Table 17. Global Human Prothrombin Complex Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Human Prothrombin Complex Price by Type (M USD/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Human Prothrombin Complex Sales by Application (K Units) & (2020-2025)
Table 21. Global Human Prothrombin Complex Sales Share by Application (2020-2025)
Table 22. Global Human Prothrombin Complex Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Human Prothrombin Complex Price by Application (M USD/Unit) & (2020-2025)
Table 24. Global Human Prothrombin Complex Sales by Application (K Units) & (2026-2031)
Table 25. Global Human Prothrombin Complex Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Human Prothrombin Complex Price by Application (M USD/Unit) & (2026-2031)
Table 27. New Sources of Growth in Human Prothrombin Complex Application
Table 28. Global Human Prothrombin Complex Sales by Company (K Units) & (2020-2025)
Table 29. Global Human Prothrombin Complex Sales Share by Company (2020-2025)
Table 30. Global Human Prothrombin Complex Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Human Prothrombin Complex Revenue Share by Company (2020-2025)
Table 32. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2024)
Table 33. Global Market Human Prothrombin Complex Average Price by Company (M USD/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application
Table 36. Global Key Manufacturers of Human Prothrombin Complex, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 39. North America Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 40. North America Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 42. North America Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 43. North America Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 44. North America Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 45. North America Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Table 46. Europe Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 47. Europe Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 48. Europe Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 50. Europe Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 51. Europe Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 52. Europe Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 53. Europe Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Table 54. China Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 55. China Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 56. China Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 58. China Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 59. China Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 60. China Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 61. China Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Table 62. Japan Human Prothrombin Complex Sales by Company (2020-2025) & (K Units)
Table 63. Japan Human Prothrombin Complex Sales Market Share by Company (2020-2025)
Table 64. Japan Human Prothrombin Complex Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Human Prothrombin Complex Revenue Market Share by Company (2020-2025)
Table 66. Japan Human Prothrombin Complex Sales by Type (2020-2025) & (K Units)
Table 67. Japan Human Prothrombin Complex Sales Market Share by Type (2020-2025)
Table 68. Japan Human Prothrombin Complex Sales by Application (2020-2025) & (K Units)
Table 69. Japan Human Prothrombin Complex Sales Market Share by Application (2020-2025)
Table 70. Takeda Company Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 73. Takeda Human Prothrombin Complex Product
Table 74. Takeda Recent Development
Table 75. CSL Company Information
Table 76. CSL Description and Business Overview
Table 77. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 78. CSL Human Prothrombin Complex Product
Table 79. CSL Recent Development
Table 80. Grifols Company Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 83. Grifols Human Prothrombin Complex Product
Table 84. Grifols Recent Development
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 88. Octapharma Human Prothrombin Complex Product
Table 89. Octapharma Recent Development
Table 90. Hualan Biological Company Information
Table 91. Hualan Biological Description and Business Overview
Table 92. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 93. Hualan Biological Human Prothrombin Complex Product
Table 94. Hualan Biological Recent Development
Table 95. Meheco Xinxing Pharma Company Information
Table 96. Meheco Xinxing Pharma Description and Business Overview
Table 97. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2020-2025)
Table 98. Meheco Xinxing Pharma Human Prothrombin Complex Product
Table 99. Meheco Xinxing Pharma Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Human Prothrombin Complex Distributors List
Table 103. Human Prothrombin Complex Customers List
Table 104. Human Prothrombin Complex Market Trends
Table 105. Human Prothrombin Complex Market Drivers
Table 106. Human Prothrombin Complex Market Challenges
Table 107. Human Prothrombin Complex Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Human Prothrombin Complex Sales Market Share by Type in 2024 & 2031
Figure 4. 500 IU/Vial Product Picture
Figure 5. 600 IU/Vial Product Picture
Figure 6. 1000 IU/Vial Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Prothrombin Complex Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 9. Global Human Prothrombin Complex Sales Market Share by Application in 2024 & 2031
Figure 10. Hemophilia B Examples
Figure 11. Vitamin K Deficiency Examples
Figure 12. Others Examples
Figure 13. Global Human Prothrombin Complex Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Prothrombin Complex Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Human Prothrombin Complex Sales (K Units) Growth Rate (2020-2031)
Figure 16. Global Human Prothrombin Complex Price Trends Growth Rate (2020-2031) & (M USD/Unit)
Figure 17. Human Prothrombin Complex Report Years Considered
Figure 18. Global Market Human Prothrombin Complex Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Human Prothrombin Complex Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Human Prothrombin Complex Sales (K Units) Growth Rate (2020-2031)
Figure 22. Europe Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Human Prothrombin Complex Sales (K Units) Growth Rate (2020-2031)
Figure 24. China Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Human Prothrombin Complex Sales (K Units) Growth Rate (2020-2031)
Figure 26. Japan Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Human Prothrombin Complex Sales (K Units) Growth Rate (2020-2031)
Figure 28. Global Human Prothrombin Complex Revenue Share by Type (2020-2025)
Figure 29. Global Human Prothrombin Complex Sales Share by Type (2026-2031)
Figure 30. Global Human Prothrombin Complex Revenue Share by Type (2026-2031)
Figure 31. Global Human Prothrombin Complex Revenue Share by Application (2020-2025)
Figure 32. Global Human Prothrombin Complex Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Human Prothrombin Complex Sales Share by Application (2026-2031)
Figure 34. Global Human Prothrombin Complex Revenue Share by Application (2026-2031)
Figure 35. Global Human Prothrombin Complex Sales Share by Company (2024)
Figure 36. Global Human Prothrombin Complex Revenue Share by Company (2024)
Figure 37. Global 5 Largest Human Prothrombin Complex Players Market Share by Revenue in Human Prothrombin Complex: 2020 & 2024
Figure 38. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Human Prothrombin Complex
Figure 40. Manufacturing Process Analysis of Human Prothrombin Complex
Figure 41. Human Prothrombin Complex Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Human Prothrombin Complex in 2025?
The global market size of Human Prothrombin Complex in 2025 was 2177 Million USD.
What was the global market size of Human Prothrombin Complex in 2031?
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2025 to 2031?
Which companies rank high in the global Human Prothrombin Complex market?
Which region is expected to have the highest market share?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now